Study S002145

A Multi-Site Trial of Tirzepatide for Smoking Cessation

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07602699
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: RECRUITING
Enrollment: 300
Start: 2026-06-05
Primary completion: 2028-03
Lead sponsor: University of Southern California
Conditions: Smoking Cessation; Smoking Behaviors
Interventions: DRUG:Tirzepatide; OTHER:Placebo
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: NIH:U01DA064384

Registered primary outcomes

7-day point prevalence abstinence [From baseline through 16 weeks of treatment (final assessment at Week 17 visit) and at 6 months after the target quit date (assessed at Week 27 visit)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.